Unknown

Dataset Information

0

Impact of postoperative radiation therapy for deeply invasive oral cavity cancer upstaged to stage III.


ABSTRACT: BACKGROUND:This article is about the eighth edition staging guidelines for upstaged patients with oral cavity squamous cell carcinoma (OCSCC) with >10?mm depth to pT3. This upstages some patients from stage I-II to stage III, a point at which patients are traditionally considered for postoperative radiation therapy (PORT). The role of PORT in patients upstaged for >10?mm depth is unknown. METHODS:We identified patients with surgically resected stage I-II OCSCC with >10?mm depth who were upstaged to stage III. We used Cox proportional hazard modeling to compare patients who received PORT to those who did not (median follow-up 38.6?months). RESULTS:We observed that 3.6% of patients with OCSCC were upstaged to stage III for depth?>10?mm including 823 eligible patients. On adjusted analyses, PORT was associated with improved overall survival in patients upstaged to stage III (adjusted hazard ratio [aHR] 0.47, 95% confidence interval [CI] 0.30-0.73). CONCLUSION:PORT is associated with improved survival for patients with OCSCC upstaged to stage III for >10?mm depth.

SUBMITTER: Cramer JD 

PROVIDER: S-EPMC6533633 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5547927 | BioStudies
2016-01-01 | S-EPMC5257334 | BioStudies
2018-01-01 | S-EPMC6607430 | BioStudies
2017-01-01 | S-EPMC5564736 | BioStudies
2017-01-01 | S-EPMC5547072 | BioStudies
2017-01-01 | S-EPMC5514239 | BioStudies
2019-01-01 | S-EPMC6768746 | BioStudies
2020-01-01 | S-EPMC7027054 | BioStudies
2021-01-01 | S-EPMC7725995 | BioStudies
2020-01-01 | S-EPMC7010496 | BioStudies